Morgan L. Bixby, BS

home / authors / morgan-l-bixby-bs

Bixby is a doctoral candidate in the Department of Experimental and Clinical Pharmacology, where Hirsch is her primary academic and research advisor.

Articles

What’s New in 2023 From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

Morgan L. Bixby, BS;Dina Zheng, PharmD Candidate;Elizabeth B. Hirsch, PharmD, RPH, FIDSA

October 25th 2023

This year's Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing provided updated breakpoints on therapies.

What’s New in 2022 From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

Elizabeth B. Hirsch, PharmD, RPH, FIDSA;Morgan L. Bixby, BS

October 26th 2022

The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing held a virtual winter meeting and a hybrid summer meeting in 2022. Ad hoc working groups have several breakpoint revisions underway for multiple organism-drug combinations.